HomesToLife Ltd financial statements

Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data HomesToLife Ltd files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2022	FY2024	FY2024	FY2025
Revenue	5.97	326	335	378
Cost of revenue	2.26	240	252	273
Gross profit	3.71	86.2	83	105
Selling and marketing	1.99	51.6	54.7	66.3
General and administrative	0.98	17.4	17.3	18.3
Operating expenses	2.97	69	73.5	85.9
Operating income	0.74	17.2	9.51	19.4
Interest expense		0.88	1.04	1.41
Interest income		0.34	0.12	0.02
Other non-operating income	0.07	-5.04	1.32	1.38
Pre-tax income	0.81	12.2	10.8	20.8
Income tax		1.86	2.42	4.2
Net income	0.81	10.3	8.42	16.6
EBITDA	0.8	17.3	9.72	19.9
EPS, basic	0.36	0.12	0.09	0.18
EPS, diluted	0.36	0.12	0.09	0.18
Shares, basic (weighted)	2.21	88.3	89.7	89.7
Shares, diluted (weighted)	2.21	88.3	89.7	89.7

Balance sheet

	FY2022	FY2024	FY2024	FY2025
Cash and equivalents	36.2	1.37	24.9	27.3
Receivables		0.11	66.9	76
Inventory		0.67	8.03	9.6
Total current assets		3.78	108	126
Property, plant and equipment		0.23	3.73	4.35
Lease right-of-use assets		3.11	6.63	7.36
Other non-current assets				1
Total assets		7.12	119	139
Accounts payable		0.99	0.27
Short-term debt			15.3	10.4
Total current liabilities		3.29	103	105
Lease liabilities		2.13	4.88	5.57
Total liabilities		5.52	108	111
Paid-in capital		28.7	37.2	37.2
Retained earnings		-23.7	-13.8	2.76
Other comprehensive income		-3.4	-12.7	-12.1
Shareholders' equity	15.7	12.1	10.7	27.8
Total equity	15.7	12.1	10.7	27.8
Total liabilities and equity		7.12	119	139
Shares outstanding		13.3	89.7	89.7

Cash flow statement

	FY2022	FY2024	FY2024	FY2025
Net income	0.81	10.3	8.42	16.6
Depreciation and amortization	0.06	0.12	0.21	0.51
Stock-based compensation			0.07
Deferred income tax		0.06	-0.15	-0.04
Change in receivables	-0.09	11	-9.55	-9.28
Change in inventory	0.03	1.96	-2.08	-1.6
Change in payables	-0.03	-1.75	2.04	3.94
Cash from operations	1.73	18.8	0.38	13.5
Capital expenditures	-0.01	-0.28	-0.52	-1.14
Purchases of investments				-1
Cash from investing	-0.01	-0.28	-0.52	-2.14
Dividends paid			-11.8
Cash from financing	-0.92	-23.3	-5.53	-9.38
Net change in cash	0.81	-4.79	-6.56	2.42
Free cash flow	1.72	18.6	-0.13	12.3
Interest paid	0.07	0.73	0.84	0.94
Income taxes paid		0.73	1.24	2.68

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $1.78 on September 23, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	27.9%	Gross profit / revenue.
Operating margin	5.1%	Operating income / revenue.
EBITDA margin	5.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	5.5%	Pre-tax income / revenue.
Net margin	4.4%	Net income / revenue.
FCF margin	3.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	3.6%	Cash from operations / revenue.
Effective tax rate	20.2%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	85.9%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	12.8%	Net income / average total assets.
Capex / revenue	0.3%	Capital expenditures / revenue.
D&A / revenue	0.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	12.8%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	298.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y	26.8%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	205.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income growth, 1y	103.7%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	196.5%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	104.5%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	191.9%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	96.6%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	172.9%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	100.0%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-20.6%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	3,405.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	98.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 3y	92.9%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y	159.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	21.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y	17.2%	Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y	0.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	243.7%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.19x	Current assets / current liabilities.
Quick ratio	0.98x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.26x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	80.0%	Total liabilities / total assets.
Interest coverage	13.8x	Operating income / interest expense.
Working capital	$20.4M	Current assets - current liabilities.
Tangible book value	$27.8M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	2.93x	Revenue / average total assets.
Fixed asset turnover	93.4x	Revenue / average property, plant and equipment.
Inventory turnover	30.9x	Cost of revenue / average inventory.
Days inventory	12 days	365 x average inventory / cost of revenue.
Receivables turnover	5.29x	Revenue / average receivables.
Days sales outstanding	69 days	365 x average receivables / revenue.
FCF conversion	74.6%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	8.4%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.18	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$0.18	Net income per basic share, as reported (split-adjusted).
Revenue per share	$4.21	Revenue / diluted weighted shares.
FCF per share	$0.14	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.15	Cash from operations / diluted weighted shares.
Book value per share	$0.31	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$0.31	Tangible book value / shares outstanding.
Cash per share	$0.30	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$159.6M	Share price x shares outstanding.
Enterprise value	$132.4M	Market cap + total debt - cash - short-term investments.
P/E	9.64x	Market cap / net income. Only when net income is positive.
P/S	0.42x	Market cap / revenue.
P/B	5.73x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	5.73x	Market cap / tangible book value, when positive.
P/FCF	12.9x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	11.8x	Market cap / cash from operations, when positive.
EV/Sales	0.35x	Enterprise value / revenue.
EV/EBIT	6.83x	Enterprise value / operating income, when both are positive.
EV/EBITDA	6.66x	Enterprise value / EBITDA, when both are positive.
EV/FCF	10.7x	Enterprise value / free cash flow, when both are positive.
FCF yield	7.7%	Free cash flow / market cap.
Earnings yield	10.4%	Net income / market cap (the inverse of P/E).

What was HomesToLife Ltd's revenue in fiscal 2025?

HomesToLife Ltd reported revenue of $377.9M for fiscal 2025, 12.8% higher than the year before.

Was HomesToLife Ltd profitable in fiscal 2025?

Yes. Net income was $16.6M, a net margin of 4.4%.

How much free cash flow did HomesToLife Ltd generate in fiscal 2025?

Cash from operations of $13.5M minus capital expenditures of $1.1M left free cash flow of $12.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to HomesToLife Ltd